HK Stock MarketDetailed Quotes

02325 YUNKANG GROUP

Watchlist
  • 11.060
  • +0.020+0.18%
Market Closed Apr 23 16:09 CST
6.87BMarket Cap-60769P/E (TTM)

About YUNKANG GROUP Company

Yunkang Group is a medical operation service provider in China. As early as 2008, Yunkang began providing standardized medical diagnosis services to medical institutions at all levels. Through the use of its professional diagnostic capabilities and medical consortium service network covering the whole country, Yunkang has gradually developed into a leading platform for medical operation services. Its testing programs have continued to increase, and it has carried out more than 2,000 testing programs and more than 50 million diagnostic tests in 2021. As far as revenue in 2020 is concerned, as one of the top five companies in the Chinese medical operation service market, we have three major business lines, covering diagnostic testing services for medical consortia, diagnostic outsourcing services, and diagnostic testing services for non-medical institution customers. As of April 25, 2022, from the establishment of six operating modules and seven major technology platforms to six independent clinical laboratories covering key provinces and cities across the country, Yunkang has the largest number of first-class independent laboratories accredited by ISO15189 and CAP in the country, as well as more than 1,450 medical technicians. We have provided comprehensive, high-quality clinical diagnosis services to partner hospitals over a long period of time with accurate clinical diagnosis capabilities. At the same time, Yunkang is also a leading medical consortium diagnostic service provider in China, providing a full range of medical and health services covering medical consortium diagnosis and diagnosis outsourcing. Yunkang provides diagnostic testing services to partner hospitals within the Chinese Medical Federation and assists them in improving their clinical diagnosis capabilities through on-site diagnostic centers. Up to now, Yunkang has successfully provided professional services to more than 700 medical institutions from more than 300 medical consortia across the country. As of December 31, 2021, the hospitals we have cooperated with are distributed in 31 provinces and cities in China, most of which are located in Guangdong Province, where our headquarters is located. Over the past ten years, Yunkang has achieved sustainable growth through professional medical diagnostic services, strong standardization capabilities, innovative diagnostic and testing service business models for medical consortia, a large loyal customer base, and a visionary and experienced management team. Technology Yunkang, service health! Yunkang will continue to work to create a better and healthy life for all residents.

Company Profile

Symbol02325
Company NameYUNKANG GROUP
ISINKYG9889T1067
Listing DateMay 18, 2022
Issue Price7.89
Shares Offered138.19M share(s)
FoundedJul 20, 2018
Registered AddressCayman Islands
Chairmanyong zhang
Secretaryluoerlinyingjia chen
Audit InstitutionChina Audit Zhonghuan (Hong Kong) Certified Public Accountants Limited
Company CategoryOverseas registration of Mainland Individuals control
Registered OfficePO Box 31119 Grand Pavilion Hibiscus Way 802 West Bay Road Grand Cayman KY1-1205 Cayman Islands
Head Office and Principal Place of BusinessRoom 1901, 19th floor, Lee Garden Phase I, 33 Hysan Avenue, Causeway Bay, Hong Kong
Fiscal Year Ends12-31
Employees1510
MarketHong Kong motherboard
Phone(020)32106666;(800)8303620;(400)8303621
Fax32106638
Emailir@yunkanghealth.com
Business Yunkang Group Co., Ltd. is a Chinese company mainly engaged in diagnostic testing services. The company operates three divisions. The Diagnostic Testing Division provides diagnostic tests for hospitals and non-medical clients, mainly including routine diagnostic tests, routine pathology tests, infectious disease diagnostic tests, genetic disease diagnostic tests, and early cancer tests. The Hospital Management business segment provides management services for community clinics. The R&D agency division is engaged in the development of test kits. The company mainly serves hospitals and other medical institutions, as well as commercial entities such as financial institutions and insurance companies.

Company Executives

  • Name
  • Position
  • Salary
  • yong zhang
  • CEO,presidencies,Executive Director,Chairman of the Nomination Committee,Remuneration Committee Members,Authorized Representative
  • --
  • luo huang
  • Non-executive directors
  • --
  • pinghui wang
  • Non-executive directors
  • --
  • ruihua wang
  • Non-executive directors,Audit Committee Members
  • --
  • shiyou yu
  • Independent Non-Executive Director,Remuneration Committee Chairman,Audit Committee Members,Nomination Committee Members
  • --
  • fenghui lan
  • Independent Non-Executive Director
  • --
  • shaohua xie
  • Independent Non-Executive Director,Chairman of the Audit Committee,Remuneration Committee Members,Nomination Committee Members
  • --
  • xubo wang
  • Executive Vice President
  • --
  • yingjia lin
  • chief financial officer,Joint Company Secretary
  • --
  • shanghua hu
  • VP
  • --
  • tieding wang
  • VP
  • --
  • luoer chen
  • Joint Company Secretary,Authorized Representative
  • --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg